Despite Medicare Coverage, Cancer Genomic Testing Still Low

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low.
Medscape Medical News

source https://www.medscape.com/viewarticle/despite-medicare-coverage-cancer-genomic-testing-still-low-2026a1000pva?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees